[1] Rodríguez-Otero P, Mateos MV , Martínez-López J, et al. Early myeloma-related death in elderly patients: development of a clinical prognostic score and evaluation of response sustainability role. Leukemia, 2018,32(11):2427-2434. [2]Yoon EL, Kim TY, Lee CH, et al. Long-term prognosis of acute-on-chronic liver failure survivors. J Clin Gastroenterol, 2019,53(2):134-141. [3] Gustot T, Moreau R. Acute-on-chronic liver failure vs. traditional acute decompensation of cirrhosis. J Hepatol, 2018,69(6):1384-1393. [4] 中华医学会感染病学分会肝衰竭与人工肝学组,中华医学会肝病学分会重型肝病与人工肝学组.肝衰竭诊治指南(2012年版). 实用肝脏病杂志, 2013, 16(3):210-216. [5] Tseng TC, Liu CJ, Su TH, et al. Fibrosis-4 index predicts cirrhosis risk and liver-related mortality in 2075 patients with chronic HBV infection. Aliment Pharmacol Ther, 2018,47(11):1480-1489. [6] Schinazi RF, Ehteshami M, Bassit L, et al. Towards HBV curative therapies. Liver Int, 2018, 38(S1):102-114. [7] Gu WY, Xu BY, Zheng X, et al. Acute-on-chronic liver failure in China: rationale for developing a patient registry and baseline characteristics. Am J Epidemiol, 2018, 187(9):1829-1839. [8] Bajaj JS, Moreau R, Kamath PS, et al. Acute-on-chronic liver failure: getting ready for prime-time. Hepatology, 2018, 68(4):1621-1632. [9] Yang L, Wu T, Li J, et al. Bacterial infections in acute-on-chronic liver failure. Semin Liver Dis, 2018, 38(2):121-133. [10] Jin J Y, Zheng YB, Zheng J, et al. 2D shear wave elastography combined withmeld improved prognostic accuracy in patients with acute-on-chronic hepatitis B liver failure. Eur Radiol, 2018, 28(10):4465-4474. [11] 曹丹, 李大江, 王颖,等. CTP联合ABIC评分预测乙型肝炎相关性慢加急性肝衰竭患者短期预后的临床意义. 中华肝脏病杂志, 2019, 27(2):118-122. [12] Szabo G. More than meets the eye: severe alcoholic hepatitis can present as acute-on-chronic liver failure. J Hepatol, 2018, 69(2):269-271. [13] Yi X, Yuan Y, Li N, et al. A mouse model with age-dependent immune response and immune-tolerance for HBV infection. Vaccine, 2018, 36(6):794-801. [14] Mahmud N, Kaplan DE, Taddei TH, et al. Incidence and mortality of acute-on-chronic liver failure using two definitions in patients with compensated cirrhosis. Hepatology, 2019, 69(5):2150-2163. [15] 马德渊, 马元凤, 张殿隆, 等. HBV相关慢加急性肝衰竭患者血清角蛋白18水平及其与患者预后的关系探讨. 实用肝脏病杂志, 2019, 22(1):82-85. [16] Wan YM, Li YH, Xu ZY, et al. Tenofovir versus entecavir for the treatment of acute-on-chronic liver failure due to reactivation of chronic hepatitis B with genotypes B and C. J Clin Gastroenterol. 2019 ,53(4):e171-e177. [17] Wu D,Sun Z, Liu X, et al. Hint: a novel prognostic model for patients with hepatitis B virus-related acute-on-chronic liver failure. Aliment Pharmacol Ther, 2018, 48(7): 750-760. [18] Durand F, Francoz C, Asrani S K, et al. Acute kidney injury after livertransplantation. Transplantation, 2018, 102(10):1636-1649. [19] Yoon EL, Kim TY, Lee CH, et al. Long-termprognosis of acute-on-chronic liver failure survivors. J Clin Gastroenterol, 2019, 53(2):134-141. [20] Blasi A, Calvo A, Prado V,et al. Coagulation failure in patients with acute-on-chronic liver failure and decompensated cirrhosis: beyond the international normalized ratio. Hepatology. 2018 ,68(6):2325-2337. [21] Huebener P, Sterneck MR, Bangert K, et al. Stabilisation of acute-on-chronic liver failure patients before liver transplantation predicts post-transplant survival. Aliment Pharmacol Ther, 2018, 47(11):1502-1510. [22] Zhou C, Wang W, Mu Y. Allogeneic mesenchymal stem cells therapy for the treatment of hepatitis B virus-related acute-on-chronic liver failure. Hepatology, 2018, 68(4):1660-1661. [23] Deep A, Saxena R, Jose B. Acute kidney injury in children with chronic liver disease. Pediatr Nephrol, 2019, 34(1):45-59. [24] Bajaj JS, Moreau R, Kamath PS,et al. Acute-on-chronic liver failure: getting ready for prime time? Hepatology, 2018, 68(4):1621-1632. [25] Xiao L, Liu Q, Zhao W,et al. Chemoembolisation with polyvinyl alcohol for advanced hepatocellular carcinoma with portal vein tumor thrombosis and arterioportal shunts: efficacy and prognostic factors. Clin Radiol, 2018, 73(12):e17-e22. |